Clinical Trials Browser

INDUSTRY × Therapeutics × Other hematologic neoplasm × Clear all

NCT05619978 2022-11-17

French Study to Highlight the Unmet Treatment Needs of 3L+ CP-CML and With T315I-mutated CML Patients

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive